Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing
Suma Krishnan, 10% Owner, Director, President, Research & Development, on June 11, 2024, sold 50,000 shares in Krystal Biotech (KRYS) for $8,788,062. Following the Form 4 filing with the SEC, Krishnan
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$8.79 Million in Common Stock
$Krystal Biotech(KRYS.US)$ 10% Shareholder Krishnan Krish S sold 50,000 shares of common stock on Jun 11, 2024 at an average price of $175.7612 for a total value of $8.79 million. This transaction inv
Form 144 | Krystal Biotech(KRYS.US) Director Proposes to Sell 4.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Krystal Biotech(KRYS.US)$ Director SUMA KRISHNAN intends to sell 25,000 shares of its common stock on Jun 11, with a total market value of approximately $4.42 million.
Top Gap Ups and Downs on Monday: KKR, CRWD, DEO and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Monday.Shares of ICC Holdings, Inc. (NASDAQ:ICCH) rose sharply during Monday's session.Mutual Capital Group announced plans to a
Texas Pacific Land Corp., Cactus Inc. Rally on Addition to S&P Indexes, While Methode Electronics Falls
Texas Pacific Land (TPL) and other stocks rallied more than 10% Monday, while Methode Elcctronics (MEI) and others fell sharply after S&P Dow Jones Indices announced plans to add or remove them from the S&P 400 MidCap or S&P SmallCap 600 indexes.
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24
KKR (KKR), CrowdStrike (CRWD), and GoDaddy (GDDY) will replace Robert Half (RHI), Comerica (CMA), and Illumina (ILMN) in the S&P 500 index from June 24, S&P Dow Jones Indices said on Friday. Illumina
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to Join S&P 600
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
PITTSBURGH, June 05, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Goldman Sachs 45th
Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio?
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Krystal Biotech (KRYS) and Veeva Systems (VEEV)
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
How Is The Market Feeling About Krystal Biotech?
Krystal Biotech's (NYSE:KRYS) short percent of float has risen 5.73% since its last report. The company recently reported that it has 2.59 million shares sold short, which is 12.0% of all regular shar
Earnings Estimates Moving Higher for Krystal Biotech (KRYS): Time to Buy?
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Krystal Biotech Insider Sold Shares Worth $3,282,690, According to a Recent SEC Filing
Julian S Gangolli, Director, on May 20, 2024, sold 20,000 shares in Krystal Biotech (KRYS) for $3,282,690. SEC Filing: https://www.sec.gov/Archives/edgar/data/1711279/000153202324000008/xslF345X03/wk-
Krystal Biotech(KRYS.US) Director Sells US$3.28 Million in Common Stock
$Krystal Biotech(KRYS.US)$ Director Gangolli Julian S sold 20,000 shares of common stock on May 20, 2024 at an average price of $164.1345 for a total value of $3.28 million.Source: Announcement What i
Krystal Biotech Currently Up Eight Consecutive Days, on Pace for Longest Winning Streak Since June 2018 -- Data Talk
Krystal Biotech, Inc. (KRYS) is currently at $172.22, up $5.39 or 3.23% --Would be highest close since April 12, 2024, when it closed at $173.62 --On pace for largest percent increase since May 1, 2
No Data